Corundum Neuroscience is a Herzliya-based venture builder and venture investment firm focused on translating neuroscience research into commercial healthcare companies. It backs and co-builds pre-seed opportunities emerging from academic research, supporting founders and researchers with long-term capital plus scientific, clinical and regulatory expertise. The firm is relevant for brain health, neurotechnology and life sciences companies across biotechnology, HealthTech, medical devices and related data, AI, hardware and internet-enabled technologies.